Researchers identify cancer drugs (Letrozole, Irinotecan) that may reverse Alzheimer's brain changes by targeting gene expression. Combination therapy shows promise in mouse model, paving way for clinical trials.
Research shows brain protein cypin is crucial for neuron communication and may combat neurodegenerative diseases like Alzheimer's and Parkinson's by tagging proteins in synapses, boosting memory and learning.
Research reveals immune system over-activation in spastic paraplegia type 15. Microglia changes and killer T-cells contribute to neuronal damage, suggesting potential immune-based therapies for this neurodegenerative disease.
